• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

农村地区的协同抗凝管理。

Coordinated anticoagulation management in a rural setting.

作者信息

Hodge Kathleen, Janus Edward, Sundararajan Vijaya, Taylor Sally, Brand Wendy, Ibrahim Joseph E, Wolff Alan

机构信息

Wimmera Health Care Group, Horsham, Victoria.

出版信息

Aust Fam Physician. 2008 Apr;37(4):280-3.

PMID:18398530
Abstract

BACKGROUND

Oral anticoagulation management is difficult in rural settings because of reduced patient access to pathology testing and medical management. Previous research reports the effectiveness of coordinated anticoagulation management incorporating education, point of care international normalised ratio (INR) testing, patient self care models, protocols and use of specially trained personnel. This article presents findings on the assessment of a Victorian rural program using a modified anticoagulation clinic and other strategies to improve anticoagulation management.

METHODS

This program assessed multiple strategies including comprehensive patient education, protocols and point of care INR testing. These were implemented in a rural hospital and rural general practices. Specific measures for evaluation were time in the therapeutic INR range and complication rate.

RESULTS

Time in the therapeutic INR range was 69% for the standard range (2.0-3.0) and 81% using an expanded range (1.8-3.0). The anticoagulation related complication rate was 0.03 per patient year (95% CI: 0.01, 0.06). International normalised ratio testing every 14 days resulted in 78% of time spent in therapeutic range.

DISCUSSION

The strategies employed in the study increased time spent in therapeutic range and reduced anticoagulation related complications.

摘要

背景

在农村地区,由于患者进行病理检查和医疗管理的机会减少,口服抗凝治疗管理存在困难。先前的研究报告了采用教育、即时国际标准化比值(INR)检测、患者自我护理模式、方案以及使用经过专门培训的人员等方式进行协调抗凝管理的有效性。本文介绍了对维多利亚州农村项目的评估结果,该项目采用了改良的抗凝门诊和其他策略来改善抗凝管理。

方法

该项目评估了多种策略,包括全面的患者教育、方案以及即时INR检测。这些策略在一家农村医院和农村全科诊所实施。评估的具体指标为处于治疗性INR范围内的时间和并发症发生率。

结果

标准范围(2.0 - 3.0)下处于治疗性INR范围内的时间为69%,使用扩大范围(1.8 - 3.0)时为81%。抗凝相关并发症发生率为每年每患者0.03(95%置信区间:0.01,0.06)。每14天进行一次国际标准化比值检测,结果显示78%的时间处于治疗范围内。

讨论

该研究采用的策略增加了处于治疗范围内的时间,并降低了抗凝相关并发症的发生率。

相似文献

1
Coordinated anticoagulation management in a rural setting.农村地区的协同抗凝管理。
Aust Fam Physician. 2008 Apr;37(4):280-3.
2
A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.一项前瞻性对照试验,比较每周自我检测和自我给药与稳定口服抗凝治疗患者的标准管理。
Thromb Haemost. 2000 May;83(5):661-5.
3
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).患者自我调整口服抗凝剂剂量能力的评估:一项关于便携式凝血酶原时间监测仪(COAGUCHECK)家庭使用的多中心研究。
Haematologica. 2000 Aug;85(8):826-31.
4
The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial.比利时口服抗凝治疗改善研究:一项随机临床试验。
Eur Heart J. 2005 Oct;26(20):2159-65. doi: 10.1093/eurheartj/ehi327. Epub 2005 May 25.
5
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.瑞典的抗凝控制:来自国家质量登记处 AuriculA 的治疗范围内时间、大出血和血栓栓塞并发症的报告。
Eur Heart J. 2011 Sep;32(18):2282-9. doi: 10.1093/eurheartj/ehr134. Epub 2011 May 26.
6
Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.华法林治疗稳定后从药剂师管理的抗凝门诊出院患者的抗凝治疗质量。
Pharmacotherapy. 2008 Jan;28(1):20-6. doi: 10.1592/phco.28.1.20.
7
Effectiveness of anticoagulation among patients discharged from hospital on warfarin. The Newcastle Anticoagulation Study Group.华法林治疗出院患者的抗凝效果。纽卡斯尔抗凝研究小组。
Med J Aust. 1998 Sep 7;169(5):243-6.
8
A randomized trial of patient self-managed versus physician-managed oral anticoagulation.一项关于患者自我管理与医生管理口服抗凝治疗的随机试验。
Can J Cardiol. 2004 Sep;20(11):1117-23.
9
Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.老年人口服抗凝治疗的自我管理:理论依据、设计、基线情况及随访一年后的口服抗凝控制。一项随机对照试验。
Thromb Haemost. 2007 Mar;97(3):408-16.
10
The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation.教育与自我监测在老年华法林治疗抗凝控制不稳定患者管理中的价值
Br J Haematol. 2004 Aug;126(4):557-64. doi: 10.1111/j.1365-2141.2004.05074.x.

引用本文的文献

1
Patient-focused interventions to support vulnerable people using oral anticoagulants: a narrative review.以患者为中心的干预措施,以支持使用口服抗凝剂的弱势群体:一项叙述性综述。
Ther Adv Drug Saf. 2019 May 13;10:2042098619847423. doi: 10.1177/2042098619847423. eCollection 2019.
2
A mechanical heart valve is the best choice.机械心脏瓣膜是最佳选择。
Heart Asia. 2016 Apr 28;8(1):62-4. doi: 10.1136/heartasia-2015-010660. eCollection 2016.